CDIOW icon

Cardio Diagnostics Holdings Inc. Warrant

0.0147 USD
-0.0024
14.04%
At close May 20, 4:00 PM EDT
1 day
-14.04%
5 days
-35.81%
1 month
-57.39%
3 months
-79.00%
6 months
-46.55%
Year to date
-82.50%
1 year
-75.54%
5 years
-95.55%
10 years
-95.55%
 

About: Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

Employees: 9

0
Funds holding %
of 7,202 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

17% more funds holding

Funds holding: 6 [Q4 2024] → 7 (+1) [Q1 2025]

0% more ownership

Funds ownership: 1.85% [Q4 2024] → 1.85% (+0%) [Q1 2025]

59% less capital invested

Capital invested by funds: $96.7K [Q4 2024] → $39.6K (-$57.1K) [Q1 2025]

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Research analyst outlook

We haven’t received any recent analyst ratings for CDIOW.

Financial journalist opinion

We haven’t received any recent news articles for CDIOW.

Charts implemented using Lightweight Charts™